Early this week, an article published in ‚ÄòSt. Louis Business Journal‚Äô made it obvious that in coming few years robotic technology would be helping surgeons or carrying out surgery themselves in medical centres globally
Early this week, an article published in ‘St. Louis Business Journal’ made it obvious that in coming few years robotic technology would be helping surgeons or carrying out surgery themselves in medical centres globally. This has persuaded several medical robotic technology manufacturers to zero in on the industry as a propelling market. According to market leaders such as ABB, Vecna Technologies, McKesson and KUKA Laboratories active in medical robot segment unveil that robotic aided surgeries has taken a elephantine leaps in 2015. Director for surgery, at the famous Southeast Alabama Medical Center, Chris Holland says, “There are some huge advantages for the patient,” said Chris Holland, director of surgery at Southeast Alabama Medical Center.
Robotic aided surgery is quite simple: Surgeons are expected to manoeuvre robots that can angle and rotate way better that a surgeon’s wrist. Comparatively the incision made by the tiny instruments are smaller than they would be if performed by a human hand. The robotic technology here is controlled by a surgeon who uses a remote control and monitors the operation via 3-D video system. In addition, observing the future prospect of the surgical robotic devices the medical robot market in 2014 was valued at approximately $3.2 billion and is expected to soar by $20 billion by the end of 2021 marked by the rise of next generation instruments and systems to perform complicated surgeries via small ports in the human body and avoiding large incisions.
Recently Research Beam has added a report titled “Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021.”As per the report the greying population of United States has backed the growth, since the increase of health problems has hiked the demand for medical devices especially by elders. To top it all, Stereotaxis this week disclosed its first-quarter revenue which was nearly $9.5 million, a rise by 14% from company’s first quarter proceeds in 2014. Thus, buoyed by great demand and marketing initiatives, the profitability margins of the medical robotic industry has grown significantly during the past four to five years.
Did you enjoy this great article?
Check out our free e-newsletters to read more great articles..